Ancillary Testing in Lung Cancer Diagnosis
Joint Authors
Dubinski, William
Hwang, David M.
Tsao, Ming-Sound
Leighl, Natasha B.
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-01-04
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
The pathologic diagnosis of lung cancer historically has relied primarily on morphologic features of tumors in histologic sections.
With the emergence of new targeted therapies, the pathologist is called upon increasingly to provide not only accurate typing of lung cancers, but also to provide prognostic and predictive information, based on a growing number of ancillary tests, that may have significant impact on patient management.
This review provides an overview of ancillary tests currently used in the pathologic diagnosis of lung cancer, with a focus on immunohistochemistry and molecular diagnostics.
American Psychological Association (APA)
Dubinski, William& Leighl, Natasha B.& Tsao, Ming-Sound& Hwang, David M.. 2012. Ancillary Testing in Lung Cancer Diagnosis. Pulmonary Medicine،Vol. 2012, no. 2012, pp.1-8.
https://search.emarefa.net/detail/BIM-457262
Modern Language Association (MLA)
Dubinski, William…[et al.]. Ancillary Testing in Lung Cancer Diagnosis. Pulmonary Medicine No. 2012 (2012), pp.1-8.
https://search.emarefa.net/detail/BIM-457262
American Medical Association (AMA)
Dubinski, William& Leighl, Natasha B.& Tsao, Ming-Sound& Hwang, David M.. Ancillary Testing in Lung Cancer Diagnosis. Pulmonary Medicine. 2012. Vol. 2012, no. 2012, pp.1-8.
https://search.emarefa.net/detail/BIM-457262
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-457262